JPY 303.0
(-0.33%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 27.58 Billion | 24.61 Billion | 31.31 Billion | 28.57 Billion | 26.69 Billion |
Cost of Revenue | 25.14 Billion | 22.38 Billion | 28.04 Billion | 25.21 Billion | 23.92 Billion |
Gross Profit | 2.43 Billion | 2.23 Billion | 3.27 Billion | 3.36 Billion | 2.77 Billion |
Operating Expenses | 1.36 Billion | 1.39 Billion | 1.36 Billion | 1.39 Billion | 1.4 Billion |
Selling, General and Administrative Expenses | 277 Million | 276 Million | 230 Million | 235 Million | 1.31 Billion |
Research and Development Expenses | 32 Million | 31 Million | 21 Million | 16 Million | 22 Million |
Other Expenses | 1.05 Billion | -35 Million | 4 Million | 8 Million | -64 Million |
Cost and Expenses | 26.5 Billion | 23.77 Billion | 29.4 Billion | 26.6 Billion | 25.32 Billion |
Operating Income | 1.07 Billion | 833 Million | 1.9 Billion | 1.96 Billion | 1.36 Billion |
Interest Expense | 14 Million | 13 Million | 21 Million | 18 Million | 16 Million |
Income Tax Expense | 347 Million | 272 Million | 600 Million | 627 Million | 444 Million |
Earnings before Tax | 1.03 Billion | 795 Million | 1.85 Billion | 1.94 Billion | 1.37 Billion |
Net Income | 685 Million | 523 Million | 1.25 Billion | 1.31 Billion | 931 Million |
Earnings Per Share Basic | 20.92 | 15.98 | 38.33 | 40.20 | 28.43 |
Earnings Per Share Diluted | 20.92 | 15.98 | 38.33 | 40.20 | 28.43 |
Weighted Average Shares Outstanding | 32.74 Million | 32.74 Million | 32.74 Million | 32.74 Million | 32.74 Million |
Weighted Average Shares Outstanding (Diluted) | 32.74 Million | 32.74 Million | 32.74 Million | 32.74 Million | 32.74 Million |
Gross Margin | 0.09 | 0.09 | 0.10 | 0.12 | 0.10 |
EBIT Margin | 0.04 | 0.04 | 0.07 | 0.07 | 0.06 |
Profit Margin | 0.02 | 0.02 | 0.04 | 0.05 | 0.03 |
EBITDA | 1.14 Billion | 921 Million | 2 Billion | 2.09 Billion | 1.53 Billion |
Earnings Before Tax Margin | 0.04 | 0.03 | 0.06 | 0.07 | 0.05 |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 7.85 Billion | 6.9 Billion | 27.58 Billion | 7.42 Billion | 7.33 Billion | 5.91 Billion |
Cost of Revenue | 7.37 Billion | 6.44 Billion | 25.1 Billion | 6.68 Billion | 6.48 Billion | 5.48 Billion |
Gross Profit | 482 Million | 459 Million | 2.47 Billion | 737 Million | 848 Million | 429 Million |
Operating Expenses | 379 Million | 328 Million | 1.38 Billion | 341 Million | 351 Million | 369 Million |
Selling, General and Administrative Expenses | 379 Million | - | - | - | - | 369 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 2 Million | 9 Million | 3 Million | 44 Million | -40 Million |
Cost and Expenses | 7.75 Billion | 6.77 Billion | 26.49 Billion | 7.02 Billion | 6.84 Billion | 5.85 Billion |
Operating Income | 103 Million | 118 Million | 1.07 Billion | 397 Million | 497 Million | 60 Million |
Interest Expense | 8 Million | 1 Million | 14 Million | 5 Million | 1 Million | 7 Million |
Income Tax Expense | 38 Million | 41 Million | 347 Million | 130 Million | 161 Million | 15 Million |
Earnings before Tax | 99 Million | 118 Million | 1.03 Billion | 400 Million | 497 Million | 18 Million |
Net Income | 61 Million | 76 Million | 685 Million | 270 Million | 337 Million | 2 Million |
Earnings Per Share Basic | 1.86 | 2.34 | - | 8.24 | 10.27 | 0.09 |
Earnings Per Share Diluted | 1.86 | 2.34 | - | 8.24 | 10.27 | 0.09 |
Weighted Average Shares Outstanding | 32.74 Million | 32.47 Million | 32.47 Million | 32.76 Million | 32.81 Million | 32.74 Million |
Weighted Average Shares Outstanding (Diluted) | 32.74 Million | 32.47 Million | 32.47 Million | 32.76 Million | 32.81 Million | 32.74 Million |
Gross Margin | 0.06 | 0.07 | 0.09 | 0.10 | 0.12 | 0.07 |
EBIT Margin | 0.02 | 0.02 | - | 0.05 | 0.07 | 0.00 |
Profit Margin | 0.01 | 0.01 | 0.02 | 0.04 | 0.05 | 0.00 |
EBITDA | 129 Million | 119 Million | - | 405 Million | 541 Million | 25 Million |
Earnings Before Tax Margin | 0.01 | 0.02 | 0.04 | 0.05 | 0.07 | 0.01 |
300054
TNTELE
2894
ARCLK
PREMEXPLN
NHPC